Northern Trust’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $43.4M | Buy |
498,514
+10,298
| +2% | +$1M | 0.01% | 1193 |
|
|
2025
Q4 | $52.3M | Sell |
488,216
-22,690
| -4% | -$2.41M | 0.01% | 1081 |
|
|
2025
Q3 | $51.6M | Buy |
510,906
+660
| +0.1% | +$61.3K | 0.01% | 1110 |
|
|
2025
Q2 | $32.2M | Sell |
510,246
-25,960
| -5% | -$1.59M | ﹤0.01% | 1367 |
|
|
2025
Q1 | $28.4M | Sell |
536,206
-9,108
| -2% | -$505K | ﹤0.01% | 1420 |
|
|
2024
Q4 | $30.5M | Buy |
545,314
+46,848
| +9% | +$2.59M | ﹤0.01% | 1436 |
|
|
2024
Q3 | $26.1M | Sell |
498,466
-982
| -0.2% | -$47.1K | ﹤0.01% | 1458 |
|
|
2024
Q2 | $20.5M | Sell |
499,448
-3,407
| -0.7% | -$136K | ﹤0.01% | 1548 |
|
|
2024
Q1 | $21.8M | Buy |
502,855
+1,761
| +0.4% | +$77.1K | ﹤0.01% | 1534 |
|
|
2023
Q4 | $23M | Sell |
501,094
-2,928
| -0.6% | -$92.4K | ﹤0.01% | 1517 |
|
|
2023
Q3 | $11.6M | Buy |
504,022
+9,820
| +2% | +$220K | ﹤0.01% | 1894 |
|
|
2023
Q2 | $8.15M | Buy |
494,202
+352,065
| +248% | +$6.35M | ﹤0.01% | 2211 |
|
|
2023
Q1 | $2.54M | Buy |
142,137
+4,036
| +3% | +$101K | ﹤0.01% | 2835 |
|
|
2022
Q4 | $4.02M | Buy |
138,101
+23,992
| +21% | +$617K | ﹤0.01% | 2615 |
|
|
2022
Q3 | $2.8M | Buy |
114,109
+2,860
| +3% | +$53.2K | ﹤0.01% | 2823 |
|
|
2022
Q2 | $462K | Sell |
111,249
-305,638
| -73% | -$1.67M | ﹤0.01% | 3562 |
|
|
2022
Q1 | $4.8M | Sell |
416,887
-12,184
| -3% | -$107K | ﹤0.01% | 2603 |
|
|
2021
Q4 | $4.28M | Buy |
429,071
+8,637
| +2% | +$97K | ﹤0.01% | 2784 |
|
|
2021
Q3 | $5.49M | Sell |
420,434
-20,252
| -5% | -$309K | ﹤0.01% | 2667 |
|
|
2021
Q2 | $8.63M | Buy |
440,686
+5,726
| +1% | +$119K | ﹤0.01% | 2474 |
|
|
2021
Q1 | $9.25M | Buy |
434,960
+16,038
| +4% | +$465K | ﹤0.01% | 2350 |
|
|
2020
Q4 | $12.5M | Sell |
418,922
-13,898
| -3% | -$353K | ﹤0.01% | 2105 |
|
|
2020
Q3 | $9.38M | Sell |
432,820
-26,903
| -6% | -$617K | ﹤0.01% | 2146 |
|
|
2020
Q2 | $10.3M | Buy |
459,723
+73,375
| +19% | +$1.43M | ﹤0.01% | 2081 |
|
|
2020
Q1 | $5.88M | Buy |
386,348
+22,952
| +6% | +$411K | ﹤0.01% | 2201 |
|
|
2019
Q4 | $8.34M | Buy |
363,396
+70,310
| +24% | +$1.56M | ﹤0.01% | 2293 |
|
|
2019
Q3 | $6.33M | Buy |
293,086
+78,588
| +37% | +$1.69M | ﹤0.01% | 2411 |
|
|
2019
Q2 | $4.72M | Sell |
214,498
-2,568
| -1% | -$64.9K | ﹤0.01% | 2598 |
|
|
2019
Q1 | $5.95M | Buy |
217,066
+6,190
| +3% | +$178K | ﹤0.01% | 2457 |
|
|
2018
Q4 | $5.67M | Sell |
210,876
-918
| -0.4% | -$25.4K | ﹤0.01% | 2424 |
|
|
2018
Q3 | $6.18M | Buy |
211,794
+67,575
| +47% | +$2.14M | ﹤0.01% | 2568 |
|
|
2018
Q2 | $4.51M | Buy |
144,219
+53,671
| +59% | +$1.47M | ﹤0.01% | 2732 |
|
|
2018
Q1 | $1.8M | Buy |
90,548
+12,367
| +16% | +$328K | ﹤0.01% | 3154 |
|
|
2017
Q4 | $2.27M | Buy |
+78,181
| New | +$2.07M | ﹤0.01% | 3075 |
|
Other funds holding RYTM
RCM
BBA
VPM
VCM
PA
Northern Trust's RYTM Position: Q1 2026 in Review
Northern Trust increased its Rhythm Pharmaceuticals (RYTM) stake by 2.1% in Q1 2026, buying an estimated $1M and bringing the position to 498,514 shares worth $43.4M. The position accounts for 0.01% of the portfolio, ranked #1193.
Northern Trust first reported a position in RYTM in Q4 2017 and has held it in 34 quarters since. The position peaked at $52.3M in Q4 2025. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.
- Northern Trust held 498,514 shares of Rhythm Pharmaceuticals worth $43.4M as of Q1 2026.
- Northern Trust bought 10,298 Rhythm Pharmaceuticals shares in Q1 2026, an estimated $1M.
- Rhythm Pharmaceuticals made up 0.01% of Northern Trust's portfolio in Q1 2026, its #1193 holding.
- Northern Trust first reported a position in Rhythm Pharmaceuticals in Q4 2017 and has held it in 34 quarters since.
- Northern Trust's Rhythm Pharmaceuticals position peaked at $52.3M in Q4 2025.
- 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.